Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Reguilon L, Gomez JH, Carrillo-Tornel S, Saiz E, Pina MF, Guzman-Almansa M, Garcia-Barbera N, Guijarro-Carrillo PJ, Herves I, Plasencia JM, Herranz MT, Lozano ML, Perez-Sanchez C, Lopez-Pedrera C, Martinez C, Gonzalez-Conejero R. Subclinical atherosclerosis in rheumatoid arthritis is driven by MicroRNA polymorphisms and NETosis. Arthritis Res Ther. 2026 Feb 9;28(1):53. doi: 10.1186/s13075-025-03727-0. PubMed PMID: 41656252; PubMed Central PMCID: PMC12918252.
AÑO: 2026; IF: 5.4
41656252
Awada H, Durmaz A, Guarnera L, Brady Z, Kubota Y, Unlu S, Gurnari C, Bravo-Perez C, Awada H, Haferlach T, Maciejewski JP, Visconte V. Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drives. Haematologica. 2026 May 7. doi: 10.3324/haematol.2026.300822. Online ahead of print. PubMed PMID: 42095235.
AÑO: 2026; IF: 8.2
42095235
Buenache N, Lasa M, Arroyo A, Gonzalez C, Haertle L, Ruiz-Heredia Y, Ayala R, Alonso R, Martin-Munoz A, Rosa-Rosa JM, Gonzalez V, Calasanz MJ, Rodriguez-Otero P, Rosinol L, De Arriba F, Ocio EM, Oriol A, Gonzalez Y, Sureda A, Lakhwani S, Clavero ME, Ibanez A, Gomez C, Orfao A, Mateos MV, Lahuerta JJ, Cedena MT, Blade J, San Miguel J, Puig N, Paiva B, Martinez-Lopez J. Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing. Hemasphere. 2026 Jun 18;10(6):e70405. doi: 10.1002/hem3.70405. eCollection 2026 Jun. PubMed PMID: 42325850; PubMed Central PMCID: PMC13278021.
AÑO: 2026; IF: 0.1
42325850
Moreno AF, Lopez de Ugarriza P, Gonzalez Huerta AJ, Pascual BB, Caceres S, Blanco LS, Calabuig ML, Zarzuela MP, Rodriguez-Veiga R, Montesinos P, Fernandez Verdugo AM, Gonzalez-Barbera EM, Izquierdo M, Medel-Plaza M, Colomina J, Olave MT, Humala K, Lopez L, Labrador J, Seral C, Amigo ML, de Toro M, Carrascoso GR, Megias G, Blazquez R, Antuna M, Lumbreras P, Dominguez JF, Bernal T. Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trial. Lancet Reg Health Eur. 2026 May 7;66:101698. doi: 10.1016/j.lanepe.2026.101698. eCollection 2026 Jul. PubMed PMID: 42164340; PubMed Central PMCID: PMC13186043.
AÑO: 2026; IF: 15.7
42164340
Wu T, Tao Y, Lu H, Cai Y, Xia Y, Liu T, Wang L, Cheng Z, Hu Y, Corral J, Tang LV. AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice. Gene Ther. 2026 Jun 1. doi: 10.1038/s41434-026-00624-2. Online ahead of print. PubMed PMID: 42225863.
AÑO: 2026; IF: 5.9
42225863
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL